XML 18 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Consolidated net income $ 894 $ 658
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 731 684
Deferred income tax benefit (21) (3)
Interest accretion on landfill liabilities 47 45
Provision for bad debts 22 21
Equity-based compensation expense 41 54
Net gain on disposal of assets (10) (5)
(Gain) loss from divestitures, asset impairments and unusual items, net (42) 29
Equity in net losses of unconsolidated entities, net of dividends 20 17
Change in operating assets and liabilities, net of effects of acquisitions and divestitures:    
Receivables 202 43
Other current assets (9) (3)
Other assets (2) (5)
Accounts payable and accrued liabilities 31 32
Deferred revenues and other liabilities (120) (32)
Net cash provided by operating activities 1,784 1,535
Cash flows from investing activities:    
Acquisitions of businesses, net of cash acquired (263) (49)
Capital expenditures (836) (631)
Proceeds from divestitures of businesses and other assets (net of cash divested) 96 13
Other, net (7) (6)
Net cash used in investing activities (1,010) (673)
Cash flows from financing activities:    
New borrowings 83 86
Debt repayments (196) (627)
Net commercial paper borrowings 443 253
Common stock repurchase program (550) (250)
Cash dividends (406) (381)
Exercise of common stock options 33 86
Tax payments associated with equity-based compensation transactions (28) (47)
Other, net (26) 21
Net cash used in financing activities (647) (859)
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents (1)  
Increase in cash, cash equivalents and restricted cash and cash equivalents 126 3
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period 293 94
Cash, cash equivalents and restricted cash and cash equivalents at end of period $ 419 $ 97